NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 175 filers reported holding NOVAVAX INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $176,000 | -69.1% | 320,289 | +3.6% | 0.00% | -100.0% |
Q4 2018 | $569,000 | +71.9% | 309,022 | +96.3% | 0.00% | 0.0% |
Q1 2018 | $331,000 | +794.6% | 157,407 | +426.6% | 0.00% | – |
Q4 2017 | $37,000 | +76.2% | 29,890 | +61.2% | 0.00% | – |
Q3 2017 | $21,000 | +5.0% | 18,540 | +5.1% | 0.00% | – |
Q2 2017 | $20,000 | -16.7% | 17,636 | -4.7% | 0.00% | – |
Q1 2017 | $24,000 | +14.3% | 18,502 | +12.1% | 0.00% | – |
Q4 2016 | $21,000 | -97.8% | 16,500 | -96.4% | 0.00% | -100.0% |
Q3 2016 | $955,000 | +86.9% | 459,000 | +552.7% | 0.01% | +66.7% |
Q2 2016 | $511,000 | +265.0% | 70,322 | +160.4% | 0.00% | – |
Q1 2016 | $140,000 | -24.3% | 27,007 | +22.8% | 0.00% | -100.0% |
Q4 2015 | $185,000 | -78.5% | 22,000 | -81.9% | 0.00% | -80.0% |
Q3 2015 | $860,000 | +0.6% | 121,733 | +58.6% | 0.01% | -16.7% |
Q2 2015 | $855,000 | +227.6% | 76,735 | +143.6% | 0.01% | +200.0% |
Q1 2015 | $261,000 | +16.5% | 31,500 | -16.6% | 0.00% | 0.0% |
Q4 2014 | $224,000 | +339.2% | 37,769 | +241.2% | 0.00% | +100.0% |
Q2 2014 | $51,000 | – | 11,068 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 265,206 | $329,000 | 0.41% |
BB BIOTECH AG | 8,330,000 | $10,329,000 | 0.29% |
QCM Cayman, Ltd. | 25,828 | $32,000 | 0.13% |
Rock Springs Capital Management LP | 2,000,000 | $2,480,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 1,215,153 | $1,507,000 | 0.09% |
IHT Wealth Management, LLC | 242,138 | $327,000 | 0.09% |
Virtu Financial LLC | 1,124,842 | $1,395,000 | 0.07% |
Telemetry Investments, L.L.C. | 150,000 | $186,000 | 0.07% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 1,023,378 | $1,269,000 | 0.04% |
CHICAGO EQUITY PARTNERS LLC | 920,900 | $1,142,000 | 0.04% |